Both recreational cannabis and CBD businesses are in strong growth mode, particularly in the US.
Similar growth is also expected in Europe.
James Linden of Greenlight Medicines, a company which takes molecules from plants (including the cannabis plant) to develop pain relief for different diseases, tells The Business about his plans.
We need your consent to load this rte-player contentWe use rte-player to manage extra content that can set cookies on your device and collect data about your activity. Please review their details and accept them to load the content.Manage Preferences
